If you've been using the Dexcom G6 and keep hearing about the G7, or if you're choosing between them for the first time, you're probably wondering what actually changed and whether the newer generation is worth it. The Dexcom G7 brought some genuinely meaningful improvements over the G6, from a much smaller design to a faster warm-up. There's also some important news about the G6's future to factor in. This guide breaks down the differences clearly so you can make the right call for your situation.
Dexcom G6 vs. Dexcom G7: Side-by-Side
According to the ADA Consumer Guide and ADCES danatech listings, here's how the two generations compare on the features that matter most:
| Feature | Dexcom G6 | Dexcom G7 |
|---|---|---|
| Design | Separate sensor and transmitter | All-in-one integrated sensor-transmitter (about 60% smaller) |
| Warm-Up Time | 2 hours | 30 minutes |
| Wear Time | 10 days | 10 days (plus 12-hour grace period) |
| MARD (Accuracy, Adult) | 9.8% | 8.2% (arm placement) |
| Reading Frequency | Every 5 minutes | Every 5 minutes |
| Calibration Required | No (optional) | No |
| Approved Insertion Sites | Abdomen; upper buttocks (ages 2-17) | Upper arm; upper buttocks (ages 2-6) |
| Predictive Low Alert | Yes (Urgent Low Soon, 20 min ahead) | Yes (Urgent Low Soon) |
| Remote Monitoring | Dexcom Follow (up to 10 followers) | Dexcom Follow (up to 10 followers) |
| Receiver Option | Yes | Yes (G7 receiver) |
| Approved Ages | 2 and older | 2 and older |
| Pregnancy Approved | Yes | Yes |
What Actually Changed from the G6 to the G7
The G7 isn't just a cosmetic refresh. Several of the changes address the most common frustrations G6 users reported, and understanding them helps clarify why the upgrade matters.
A much smaller, all-in-one design. The ADCES notes that the Dexcom G7 features roughly a 60% decrease in size compared to the G6. Just as significantly, the G6 used a separate sensor and reusable transmitter that you had to snap together and move between sensors, while the G7 combines both into a single disposable unit. This means fewer steps at each sensor change, no transmitter to keep track of, and less packaging waste.
A dramatically faster warm-up. One of the most appreciated improvements is warm-up time. The G6 required a 2-hour warm-up before it began showing readings after insertion. The G7 cut that to just 30 minutes, and the warm-up begins automatically as soon as the sensor is applied. For anyone who has waited two hours without glucose data after a sensor change, this is a meaningful quality-of-life improvement.
Improved accuracy and a grace period. The G7 carries a lower MARD (a measure of accuracy where lower is better) than the G6, at about 8.2% for arm placement versus 9.8% for the G6 in adults. The G7 also added a 12-hour grace period at the end of each 10-day session, giving you extra time to replace an expiring sensor without an abrupt cutoff.
Different approved insertion sites. The two generations are approved for different placement locations. The G6 is approved for the abdomen (and the upper buttocks for ages 2 to 17), while the G7 is approved for the back of the upper arm (and the upper buttocks for ages 2 to 6). If you have a strong preference for or against a particular site, this difference is worth noting.
Dexcom has also released a G7 15-Day version, which according to the ADA Consumer Guide offers an extended 15.5-day wear time and an even lower MARD of 8.0% for adults 18 and over, though it is not currently insulin pump compatible. This gives you another option to discuss with your provider depending on your needs.
Should You Upgrade, and What About the G6's Future?
For most G6 users, the G7 represents a clear improvement, but there are a few considerations that factor into the decision.
The case for upgrading. The smaller size, faster warm-up, improved accuracy, simpler all-in-one design, and end-of-session grace period all make the G7 more convenient and comfortable for the large majority of users. If those improvements appeal to you, the G7 is a strong choice.
The pump compatibility consideration. Historically, one reason some users stayed on the G6 was insulin pump and app integration, since pump partners needed time to add G7 support. That landscape has largely caught up. The G7 now integrates with major AID systems including the Tandem t:slim X2 with Control-IQ, the Tandem Mobi, the Omnipod 5, and the Beta Bionics iLet. If you use a pump, confirm that your specific system supports the G7 before switching, but for most current pump platforms, G7 compatibility is now available.
Important news about the G6. This is the biggest factor for many people. According to the ADCES, Dexcom has announced that the G6 will be manufactured only until July 1, 2026. While supplies may remain available through pharmacies and distributors for some time after that date, Dexcom cannot guarantee availability afterward and is encouraging users to transition to either the G7 or the G7 15-Day. This planned phase-out means that, for most people, moving to the G7 is not just an upgrade but eventually a necessity, so starting the transition sooner rather than later makes practical sense.
Switching from the G6 to the G7 requires a new prescription specifying the G7, and your insurance coverage may need to be re-verified for the new device. Our team at Adapt Health Diabetes can help coordinate that transition. It's completely normal to feel attached to a device you've gotten comfortable with, and a brief adjustment period as you learn the G7's slightly different application and app is expected.
Why Choosing the Right Generation Matters
Your CGM is something you wear and rely on every day, so the differences between generations genuinely affect your daily experience. A faster warm-up means less time without data. A smaller sensor means more comfort. Better accuracy means more confidence in the readings driving your decisions. And with the G6 heading toward phase-out, understanding the G7 helps you plan a smooth transition rather than scrambling later. Whichever device you choose, the goal is reliable, comfortable, accurate monitoring that fits your life. At Adapt Health Diabetes, we carry the full Dexcom lineup and can help verify your coverage and coordinate a switch. Visit our Learning Center and Education page for more guides comparing CGM options.
Frequently Asked Questions About Dexcom G6 vs. G7
Is the Dexcom G6 being discontinued?
Dexcom has announced that the G6 will be manufactured only until July 1, 2026. Supplies may continue to be available through pharmacies and distributors for a period after that date, but availability is not guaranteed afterward. Dexcom is encouraging G6 users to transition to the G7 or the G7 15-Day. Because of this planned phase-out, most current G6 users will eventually need to switch, so it's worth starting the conversation with your provider and supplier sooner rather than later to ensure a smooth transition.
Is the G7 more accurate than the G6?
Yes, modestly. The G7 carries a lower MARD (the standard accuracy metric, where lower is better) at about 8.2% for arm placement in adults, compared to 9.8% for the G6. Both are well within the range considered clinically reliable for treatment decisions, so the practical difference for everyday management is real but not dramatic. The G7 15-Day version offers an even lower adult MARD of 8.0%. Accuracy is just one factor, though; the G7's faster warm-up and smaller size are often the more noticeable day-to-day improvements.
Will my insulin pump work with the G7?
In most cases, yes. The G7 now integrates with the major automated insulin delivery systems, including the Tandem t:slim X2 with Control-IQ, the Tandem Mobi, the Omnipod 5, and the Beta Bionics iLet. When the G7 first launched, pump integration lagged, which kept some users on the G6, but that gap has largely closed. Before switching, confirm that your specific pump system and software version support the G7, which our team or your pump manufacturer can help you verify.
Do I need a new prescription to switch from the G6 to the G7?
Yes. Moving from the G6 to the G7 requires an updated prescription specifying the G7, and your insurance may need to be re-verified for the new device. The process is generally straightforward, especially if you're an established CGM user with active coverage. Our team at Adapt Health Diabetes can coordinate with your provider's office and your insurer to make the transition smooth and confirm your out-of-pocket costs before anything ships.
Can I wear the G7 on my abdomen like I did with the G6?
Not in the United States. The G6 is approved for the abdomen, but the G7 is FDA-approved for the back of the upper arm (and the upper buttocks for children ages 2 to 6). If you preferred abdominal placement with the G6, this is a change to be aware of when switching. Many people find the upper arm site comfortable and convenient, but it's a genuine difference between the two generations worth factoring into your decision and your site rotation planning.
Make the Switch to the Dexcom G7 Through Your Insurance
Whether you're upgrading from the G6 or starting fresh, Adapt Health Diabetes carries the full Dexcom lineup, including the G7 sensor and G7 receiver. We verify your insurance, coordinate with your provider, and deliver directly to your door. Visit our Resources page for more information, or contact our team to start your transition.
This article is for educational purposes only and does not replace professional medical advice. Always consult your healthcare provider regarding CGM selection and diabetes management decisions. Product availability and compatibility are subject to change.
Sources
- American Association of Diabetes Care and Education Specialists. Dexcom G7 Features. danatech by ADCES.
- American Diabetes Association. Dexcom G6 CGM System. ADA Consumer Guide.
- American Diabetes Association. Dexcom G7 and G7 15-Day CGM System. ADA Consumer Guide.
- American Association of Diabetes Care and Education Specialists. Dexcom G6 Features. danatech by ADCES.
